Inventor · disambiguated record
Graham P. Allaway
Also filed as: ALLAWAY GRAHAM · ALLAWAY GRAHAM P
21 granted patents·15 pending applications·513 citations·filing 1993–2011
96Inventor score
Files withPROGENICS PHARM INC22PANACOS PHARMACEUTICALS INC7AARON DIAMONDS AIDS RES CT ADA1ALLAWAY GRAHAM P1SALZWEDEL KARL1
Top patents by PatentIndex Score
36 records- 0195US7345153B2Compounds capable of inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2006·Granted Mar 18, 2008·23 cites·7 claims
- 0292US6344545B1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Feb 5, 2002·91 cites·6 claims
- 0391US7118859B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Oct 10, 2006·30 cites·8 claims
- 0489US7365221B2Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereofPANACOS PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·32 cites·23 claims
- 0589US6034223ANon-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 1995·Granted Mar 7, 2000·69 cites·8 claims
- 0687US5817767ASynergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using samePROGENICS PHARM INC·Filed 1993·Granted Oct 6, 1998·73 cites·6 claims
- 0786US6261763B1Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusionPROGENICS PHARM INC·Filed 1996·Granted Jul 17, 2001·38 cites·9 claims
- 0886US6107019AMethod for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Aug 22, 2000·78 cites·12 claims
- 0977US7935797B2CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusionPROGENICS PHARM INC·Filed 2007·Granted May 3, 2011·1 cites·1 claims
- 1077US6972126B2Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing samePROGENICS PHARM INC·Filed 1999·Granted Dec 6, 2005·33 cites·3 claims
- 1176US6737267B2Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 2001·Granted May 18, 2004·3 cites·48 claims
- 1276US6605427B2Assay for detection of viral fusion inhibitorsPANACOS PHARMACEUTICALS INC·Filed 2001·Granted Aug 12, 2003·14 cites·19 claims
- 1371US6768007B2Substituted 3′,4′-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereofPANACOS PHARMACEUTICALS INC·Filed 2002·Granted Jul 27, 2004·5 cites·23 claims
- 1470US7537765B2Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinPANACOS PHARMACEUTICALS INC·Filed 2004·Granted May 26, 2009·3 cites·40 claims
- 1570US2009155774A1Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cellPROGENICS PHARM INC·Filed 2009·Application pending·0 cites
- 1666US6177549B1Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 1999·Granted Jan 23, 2001·10 cites·8 claims
- 1763US7901685B2Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusionPROGENICS PHARM INC·Filed 2005·Granted Mar 8, 2011·0 cites·3 claims
- 1863US2008226651A1Compounds capable of inhibiting hiv-1 infectionPROGENICS PHARM INC·Filed 2008·Application pending·0 cites
- 1960US7862994B2Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusionPROGENICS PHARM INC·Filed 2001·Granted Jan 4, 2011·0 cites·4 claims
- 2059US2008233559A1Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 ProteinUS GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 2159US2008187539A1Method for preventing HIV-1 infection of CD4 cellsPROGENICS PHARM INC·Filed 2007·Application pending·0 cites
- 2257US6083478ANon-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 Immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 1994·Granted Jul 4, 2000·9 cites·8 claims
- 2357US2008039428A1Antiretroviral combination therapyPANACOS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2456US8318425B2Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinSALZWEDEL KARL·Filed 2009·Granted Nov 27, 2012·0 cites·1 claims
- 2554US2006029932A1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 2005·Application pending·0 cites
- 2654US2006194244A1Uses of a chemokine receptor for inhibiting HIV-1 infectionAARON DIAMONDS AIDS RES CT ADA·Filed 2006·Application pending·0 cites
- 2754US2013211043A1Method for preventing hiv-1 infection of cd4+ cellsALLAWAY GRAHAM P·Filed 2011·Application pending·0 cites
- 2851US2008200550A1Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 ProteinVI TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 2948US2002155429A1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 2001·Application pending·0 cites
- 3046US2004265320A1Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinFiled 2004·Application pending·0 cites
- 3146US2002010317A1Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteinsFiled 2001·Application pending·0 cites
- 3244US2004131629A1Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereofPANACOS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3344US2004086528A1Uses of a chemokine receptor for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Application pending·0 cites
- 3442US2004132011A1Method for detecting viral inactivating agentsPANACOS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3539US7858298B1Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonistsPROGENICS PHARM INC·Filed 1999·Granted Dec 28, 2010·1 cites·6 claims
- 3633US6342586B1Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates and uses thereofPROGENICS PHARM INC·Filed 1999·Granted Jan 29, 2002·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Graham P. Allaway files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →